Zurueck zur Suche

Reporte zur Charge U002394

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

19Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MI 8 KY 3 VA 1 TX 1 MS 1 NJ 1 NC 1 OK 1 SC 1

VAERS 1963569

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U002394

schwer
Staat
KY
Alter
12,0
Geschlecht
M
Eingang
20.12.2021
Impfdatum
16.12.2021
Beginn
16.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Anxiety Crying Depressed mood Dizziness Fatigue Hypoaesthesia oral Pallor Paraesthesia oral Presyncope Stress

Symptomtext

Pt at clinic with mom for imm. Pt was to receive 7 vaccines and became upset and anxious. Mom tried to comfort pt , but he was visible stressed and crying. I asked another nurse to help as stand-by. I was able to administer the first three vaccines in pt's right arm. Pt stopped crying and laughed saying "it didn't hurt." The the pt's face got pale and he stopped laughing. He appeared close to fainting. Pt stated he felt dizzy and his tongue felt tingly or numb. Pt was not short of breath and his airway was open upon inspection. Pt appeared tired, but never lost consciousness. After giving him 5 - 10 minutes and a drink of water, he stated he was ok. After discussing the incident with pt's mom, we decided to defer the rest of the vaccines until the next week. Reviewed with mom the s x s of allergies, and that she should take him to the ER if they develop. Mom verbalized understanding.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Presyncope
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
No prescription meds, OTC unknown
Allergien
None
Vorherige Impfungen
-

VAERS 1747763

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U002394

schwer
Staat
VA
Alter
16,0
Geschlecht
M
Eingang
30.09.2021
Impfdatum
31.08.2021
Beginn
31.08.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Hyperhidrosis Pallor Syncope

Symptomtext

Pallor, diaphoresis, syncope

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none known
Vorgeschichte
none known
Andere Medikamente
none known
Allergien
no
Vorherige Impfungen
-

VAERS 1917284

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U002394

mild
Staat
MI
Alter
38,0
Geschlecht
F
Eingang
02.12.2021
Impfdatum
16.09.2021
Beginn
17.09.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Feeling hot Pain in extremity Peripheral swelling Rash Swelling

Symptomtext

Patient described a local reaction on her right arm that was warm to the touch, painful, and swollen that started approximately the day after the vaccine was given and lasted about 5 days. She said also, about 1-2 days after vaccination she started seeing a rash on her right arm, mostly forearm, that has since spread to her other arm and stomach; now it is on her hands somewhat. She has been taking Benadryl, which has helped the itching. When asked to describe the way the rash looks, she denies any fluid filled looking bumps, but says yes to red raised bumps.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
Prednisone given for swelling and itching for 5 days, NP said it was a "typical reaction"
Aktuelle Erkrankungen
none
Vorgeschichte
optic neuritis, RA, Depression, Anxiety
Andere Medikamente
omeprazole, Pristiq, Buspar, Antivert, Aspirin, vitamin B3, ano
Allergien
NKA
Vorherige Impfungen
-

VAERS 1541022

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U002394

mild
Staat
TX
Alter
16,0
Geschlecht
M
Eingang
10.08.2021
Impfdatum
09.08.2021
Beginn
09.08.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Inappropriate schedule of product administration Pain in extremity

Symptomtext

Patient was vaccinated twice within recent days by mistake. Patient mentioned having some arm pain shortly and was evaluated by a provider. Physician mentions patient is stable and has scheduled him for a follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
NONE
Allergien
NONE
Vorherige Impfungen
-

VAERS 2582428

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U002394

gering
Staat
MS
Alter
1,1
Geschlecht
M
Eingang
15.02.2023
Impfdatum
07.02.2023
Beginn
07.02.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

no adverse event; expired varicella virus vaccine live (Oka/Merck) (VARIVAX) was administered to a patient in error; This spontaneous report was received from a nurse and refers to a 13-month-old male patient. The patient's pertinent medical history, concurrent conditions, previous drug reactions or allergies, and concomitant therapies were not reported. On 07-FEB-2023, the patient was vaccinated with an expired varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, lot #U002394, was confirmed to be a valid lot number, expiration date: 22-JAN-2023, administered subcutaneously for prophylaxis (strength, dose, and anatomical site injection were not provided) (expired product administered). No additional AE reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2355655

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge u002394

gering
Staat
NJ
Alter
1,1
Geschlecht
U
Eingang
03.07.2022
Impfdatum
16.10.2021
Beginn
11.11.2021
Tage bis Beginn
26,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration No adverse event

Symptomtext

No additional AEs were reported; patient received MMR II and VARIVAX shorter than recommended interval. The patient received MMR II on 10/16/2021 and VARIVAX on 11/11/2021.; This spontaneous report was received from a registered nurse and refers to a 13-month-old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 16-OCT-2021, the patient was vaccinated with 1 dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) subcutaneous injection, recombinant human albumin (rHA), lot # t022310, expiration date: 30-JUN-2022, for prophylaxis (strength, and route of administration were not provided). On 11-NOV-2021, the patient was vaccinated with 1 dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 1 dose, lot # u002394, expiration date: 22-JAN-2023, for prophylaxis (strength, and route of administration were not provided) (inappropriate schedule of product administration). No additional adverse events were reported (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2192285

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U002394

gering
Staat
KY
Alter
1,1
Geschlecht
F
Eingang
22.03.2022
Impfdatum
16.03.2022
Beginn
16.03.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Wrong product administered

Symptomtext

Patient was given MMRV (Proquad) instead of MMR. This was realized on 3/21/22 during a vaccine count. Lot # of vaccine administered was determined to be MMRV and not MMR. (The packaging on MMR and MMRV are very similar and the vaccine locations were switched in the fridge on accident.) Patient's father was called as soon as mistake was realized. Patient's father said that she was doing fine and had no adverse reactions or concerns.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
NKA
Vorherige Impfungen
-

VAERS 2192248

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U002394

gering
Staat
KY
Alter
1,0
Geschlecht
M
Eingang
22.03.2022
Impfdatum
10.03.2022
Beginn
10.03.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Wrong product administered

Symptomtext

Patient was given MMRV (Proquad) instead of MMR. This was realized on 3/21/22 during a vaccine count. Lot # of vaccine administered was determined to be MMRV and not MMR. Patient's mother was called as soon as mistake was realized. Patient's mother said that pt. was doing fine and had no adverse reactions or concerns.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
None
Vorgeschichte
-
Andere Medikamente
None
Allergien
NKA
Vorherige Impfungen
-

VAERS 1810118

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U002394

gering
Staat
MI
Alter
4,0
Geschlecht
U
Eingang
23.10.2021
Impfdatum
11.09.2021
Beginn
11.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

No additional AE's/PQC's reported; temperature excursion for VARlVAX; This spontaneous report was received from a registered nurse referring to an 4 years old patient of unknown gender. The patient's concurrent conditions, medical history and concomitant medications were not provided. On 11-SEP-2021, the patient was vaccinated with varicella virus vaccine live (Oka/Merck) (VARIVAX) 1 dose (strength, dose, route, frequency, were not provided) for prophylaxis; Lot# U002394 has been verified to be a valid lot number for [varicella virus vaccine live (Oka/Merck)], expiration date reported as 22-JAN-2023, and upon internal validation established as the same. The nurse reported that the vaccine dose was administered on 11-SEP-2021 and there was a temperature excursion for varicella virus vaccine live (Oka/Merck) (VARIVAX). The product experienced an excursion of 4 Celsius degrees (C) from -10 C to 8 C for 20 minutes on 07-SEP-2021 during the transport; and of 4C from -10 C to 8 C for 20 minutes on 09-SEP-2021, again during transport. Previous temperature excursion included from -10 C to 8 C (4C) for 7 hours and 30 minutes. And no adverse events were reported. This is one of 26 reports received from the same reporter.; Sender's Comments: US-009507513-2109USA005628: US-009507513-2109USA005648: US-009507513-2109USA005662: US-009507513-2109USA005760:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1797057

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U002394

gering
Staat
MI
Alter
0,1
Geschlecht
U
Eingang
19.10.2021
Impfdatum
13.09.2021
Beginn
13.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age Product storage error

Symptomtext

No additional AE's; a temperature excursion for VARlVAX; the patients dob: 23-JUL-2021; This spontaneous report has been received from a registered nurse (also reported as medical assistant), referring to a 7 weeks old patient of unknown gender. Information regarding the patient's pertinent medical history, concurrent condition and concomitant medication was not provided. The reporter to report a temperature excursion for varicella virus vaccine live (oka/merck) (VARIVAX). Per the reporter, varicella virus vaccine live (oka/merck)(VARIVAX) experienced an excursion of (4 degree Celsius (C)) for 20 minutes on 07-SEP-2021 during transport and (4C) for 20 minutes on 09-SEP-2021 during transport. On 13-SEP-2021, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) (lot#U002394 with expiration date: 22-JAN-2023; dose: 1 (units not provided), strength and route were unknown) for prophylaxis (product storage error and product administered to patient of inappropriate age). No additional AE reported. Administered dose of varicella virus vaccine live (oka/merck) (VARIVAX) experienced the temperature excursion under 10C below zero to 8C (4C) for 20 minutes and 10C below zero to 8C (4C) for 20 minutes. There previous temperature excursion was under 10C below zero to 8C (4C) for 7 hours and 30 minutes. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2109USA005628: US-009507513-2109USA005632: US-009507513-2109USA005639: US-009507513-2109USA005641: US-009507513-2109USA005648: US-009507513-2109USA005651: US-009507513-2109USA005701: US-009507513-2109USA005705: US-009507513-2109USA005730: US-009507513-2109USA005742: US-009507513-2109USA005744: US-009507513-2109USA005752: US-009507513-2109USA005758: US-009507513-2109USA005760: US-009507513-2109USA005881: US-009507513-2109USA005891: US-009507513-2109USA005901: US-009507513-2109USA005902: US-009507513-2109USA005910: US-009507513-2109USA005918: US-009507513-2109USA005945: US-009507513-2109USA005964: US-009507513-2109USA006765: US-009507513-2109USA005776: US-009507513-2109USA005618: US-009507513-2109USA005662:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1797056

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U002394

gering
Staat
MI
Alter
4,0
Geschlecht
U
Eingang
19.10.2021
Impfdatum
09.09.2021
Beginn
09.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE's/PQC's reported; products experienced an excursion; This spontaneous report has been received from a medical assistant referring to a 4 year old patient with unknown gender. The patient's medical history, concurrent condition and concomitant medication were not reported. On 07-SEP-2021 during transport varicella virus vaccine live (oka/merck) (VARIVAX) experienced temperature excursion of -10 Degrees Celsius to 8 Degrees Celsius (4C) for 20 minutes and on 09-SEP-2021 -10 Degrees Celsius to 8 Degrees Celsius (4C) for 20 minutes. Previous temperature excursion included -10 Degrees Celsius to 8 Degrees Celsius (4C) for 7 hours and 30 minutes. On 09-SEP-2021 the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) (1 dosage form; lot # U002394, expiration date 22-JAN-2023; route and strength were unknown) for prophylaxis (Product storage error). No additional adverse event was reported (No adverse event). This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2109USA005628: US-009507513-2109USA005648: US-009507513-2109USA005662: US-009507513-2109USA005618: US-009507513-2109USA005639: US-009507513-2109USA005632: US-009507513-2109USA005910: US-009507513-2109USA005742: US-009507513-2109USA005891: US-009507513-2109USA005964: US-009507513-2109USA005651: US-009507513-2109USA005918: US-009507513-2109USA005758: US-009507513-2109USA005760: US-009507513-2109USA005705: US-009507513-2109USA005776: US-009507513-2109USA005901: US-009507513-2109USA005752: US-009507513-2109USA005641: US-009507513-2109USA005945: US-009507513-2109USA005881: US-009507513-2109USA005902: US-009507513-2109USA005701: US-009507513-2109USA005795: US-009507513-2109USA005730: US-009507513-2109USA006765:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1739876

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U002394

gering
Staat
MI
Alter
4,0
Geschlecht
U
Eingang
28.09.2021
Impfdatum
13.09.2021
Beginn
13.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

No additional AE's; products experienced an excursion of ( 4C) for 20 minutes on 9/7 during transport and ( 4C) for 20 minutes on 9/9 during transport.; This spontaneous report as received from a registered nurse refers to a 4-year-old patient of unknown gender. The patient's concurrent conditions, medical history, and concomitant therapies were not reported. The varicella virus vaccine live (oka/merck)(VARIVAX) vaccine experienced an excursion of ( 4?C) for 20 minutes on 07-SEP-2021 during transport and ( 4?C) for 20 minutes on 09-SEP-2021 during transport. On 13-SEP-2021, the patient was vaccinated with an inappropriate storage dose of varicella virus vaccine live (oka/merck)(VARIVAX) lot # U002394 and expiration date 22-JAN-2023, dose reported as 1 (units not provided) (strength and route were not reported) for prophylaxis. The temperature and Time frame was reported as -10?C to 8?C ( 4?C) for 20 minutes. There was a previous temperature excursion, which was -10?C to 8?C ( 4?C) for 7 hours and 30 minutes. No additional events were reported. This is one of several cases received from the same reporter.; Sender's Comments: US-009507513-2109USA005618: US-009507513-2109USA005628: US-009507513-2109USA005632: US-009507513-2109USA005639: US-009507513-2109USA005641: US-009507513-2109USA005648: US-009507513-2109USA005651: US-009507513-2109USA005662: US-009507513-2109USA005730: US-009507513-2109USA005795: US-009507513-2109USA005891: US-009507513-2109USA005964: US-009507513-2109USA005628:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1739874

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U002394

gering
Staat
MI
Alter
-
Geschlecht
U
Eingang
28.09.2021
Impfdatum
-
Beginn
09.09.2021
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

No additional AE's/PQC's reported; Temperature excursion for VARIVAX; This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. The patient's concurrent conditions, medical history, and concomitant medications were not reported. On 09-SEP-2021, the patient was vaccinated with varicella virus vaccine live (oka/merck)(VARIVAX) (strength, dose, anatomical location, and route of administration were not reported) (lot# U015682 with an expiration date on 18-MAY-2023 and lot# U002394 with an expiration date on 22-JAN-2023) for prophylaxis wich experienced a temperature excursi?n of 4?C Celsius degrees for 20 minutes on 07-SEP-2021 during transport and 4?C for 20minutes on 09-SEP-2021 during transport as well as -10?C to 8?C (4?C) for 20 minutes (product storage error). It was reported previous temperature excursions of -10?C to 8?C (4?C) for 7 hours and 30 minutes. No additional adverse events were reported.; Sender's Comments: US-009507513-2109USA005628:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1736182

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U002394

gering
Staat
MI
Alter
5,0
Geschlecht
U
Eingang
27.09.2021
Impfdatum
13.09.2021
Beginn
13.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

No additional AE's/PQC's reported; temperature excursion for VARlVAX / have been administered to patients; This spontaneous report was received from a registered nurse (also reported as a certified medical assistant) and refers to a 5-year-old patient of an unknown gender. No information regarding the patient's medical history, concurrent conditions or concomitant medications was provided. On 13-SEP-2021, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) one dose, lot # U002394 was confirmed to be valid, expiration date 22-JAN-2023, for prophylaxis (dose, route and site of administration were not reported). The administered dose was exposed to the temperature from -10 degrees Celsius (C) to 8 C (4 C) for 20 minutes on 07-SEP-2021 and from -10 C to 8 C (4 C) for 20 minutes 09-SEP-2021 (both during transport). There was also previous temperature excursion reported as from -10 C to 8 C for 7 hours and 30 minutes. No additional adverse event was reported; Sender's Comments: US-009507513-2109USA005628:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1736180

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U002394

gering
Staat
-
Alter
1,0
Geschlecht
U
Eingang
27.09.2021
Impfdatum
13.09.2021
Beginn
13.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

No additional AE's/PQC's reported; Improperly Stored; Administered; This spontaneous report was received from a registered nurse (also reported as a certified medical assistant) and refers to a 12-month-old patient of an unknown gender. No information regarding the patient's medical history, concurrent conditions or concomitant medications was provided. On 13-SEP-2021, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) one dose, lot # U002394 was confirmed to be valid, expiration date 22-JAN-2023, for prophylaxis (dose, route and site of administration were not reported). The administered dose was exposed to the temperature from -10 degrees Celsius (C) to 8 C (4 C) for 20 minutes on 07-SEP-2021 and from -10 C to 8 C (4 C) for 20 minutes 09-SEP-2021 (both during transport). There was also previous temperature excursion reported as from -10 C to 8 C for 7 hours and 30 minutes. No additional adverse event was reported; Sender's Comments: US-009507513-2109USA005628:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1733756

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U002394

gering
Staat
MI
Alter
4,0
Geschlecht
U
Eingang
25.09.2021
Impfdatum
-
Beginn
10.09.2021
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

no AE; expirienced an excursion; This spontaneous report was received from a nurse referring to a 4-years-old patient of unknown gender. For all the patients, the concurrent conditions, medical history and concomitant medications were not provided. On 10-SEP-2021, the patient was vaccinated with varicella virus vaccine live (Oka/Merck) (VARIVAX) 1 dose (strength, dose, route, frequency, were not provided) for prophylaxis; Lot No. U015682 has been verified to be a valid lot number for [varicella virus vaccine live (Oka/Merck)], expiration date reported as 18-MAY-2023, and upon internal validation established as the same. The nurse reported that the vaccine dose was administered on 10-SEP-2021 and there was a temperature excursion for varicella virus vaccine live (Oka/Merck) (VARIVAX). The product experienced an excursion of 4 Celsius degrees (C) from -10 C to 8 C for 20 minutes on 07-SEP-2021 during the transport; and of 4C from -10 C to 8 C for 20 minutes on 09-SEP-2021, again during transport. Previous temperature excursion included from -10?C to 8?C (4C) for 7 hours and 30 minutes. And no adverse events were reported. This is one of four reports received from the same source.; Sender's Comments: US-009507513-2109USA005618: US-009507513-2109USA005628: US-009507513-2109USA005632: US-009507513-2109USA005639:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1706463

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge U002394

gering
Staat
NC
Alter
30,0
Geschlecht
F
Eingang
17.09.2021
Impfdatum
14.09.2021
Beginn
14.09.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Incorrect route of product administration

Symptomtext

Error: Wrong Route (SC, IM, etc.)-

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect route of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1666646

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U002394

gering
Staat
OK
Alter
22,0
Geschlecht
M
Eingang
02.09.2021
Impfdatum
01.09.2021
Beginn
01.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered

Symptomtext

VARICELLA GIVEN ON 9/1/21 AND B.U.D WAS 8/31/21.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
NONE
Allergien
NONE
Vorherige Impfungen
-

VAERS 1518496

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge u002394

gering
Staat
SC
Alter
28,0
Geschlecht
F
Eingang
31.07.2021
Impfdatum
31.07.2021
Beginn
31.07.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Wrong product administered

Symptomtext

Gave MMR and Varivax IM instead of SQ - No reaction just wanted to report

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-